Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2089–2124
Headlines
3750
Sources here
11
Companies here
17
Current section United States Diagnostics & Research news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ACHC|Acadia Healthcare Company Inc|Price:27.340|Chg%:-5.350

TradingKey provides a comprehensive stock analysis of Acadia Healthcare Company Inc (ACHC), highlighting its stable fundamentals, significant growth potential, and "fairly valued" status within the Healthcare Providers & Services industry. The report notes high institutional ownership and recent "Buy" ratings from analysts, with a …

DGX mentioned LH mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royal Bank of Canada Acquires 133,549 Shares of Labcorp Holdings Inc. $LH

Royal Bank of Canada increased its stake in Labcorp Holdings Inc. by 19.4%, acquiring an additional 133,549 shares, bringing its total to 820,442 shares valued at approximately $218.9 million. Labcorp surpassed quarterly earnings expectations with $4.25 EPS and $3.54 billion in revenue, leading to …

LH mentioned
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Maverick Capital Ltd. Has $426,000 Position in Labcorp Holdings Inc. $LH

Maverick Capital Ltd. significantly reduced its stake in Labcorp Holdings Inc. (NYSE:LH) by 90.9% in the first quarter, now holding 1,596 shares valued at $426,000. Despite this reduction, Labcorp reported strong financial results, beating EPS estimates with $4.25 and growing revenue by 5.8% to …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TOI|Oncology Institute Inc|Price:4.755|Chg%:-0.195

This article provides a comprehensive stock analysis of Oncology Institute Inc (TOI), highlighting its strong fundamentals, high growth potential, and fair valuation within the Healthcare Providers & Services industry. It notes a high institutional ownership and a positive outlook from analysts, with a highest …

DGX mentioned LH mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mettler-Toledo International, Inc. $MTD Shares Sold by Edgestream Partners L.P.

Edgestream Partners L.P. decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 11.7% in the first quarter, selling 1,039 shares and retaining 7,834 shares worth $9.88 million. Other institutional investors have also adjusted their stakes, with overall institutional ownership at 95.07%. Mettler-Toledo recently reported …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Natera Inc (NTRA) Valuation: PE, PB & Fair Value Analysis

Natera Inc (NTRA) currently holds a valuation score of 9.78, placing it 3rd among 75 companies in the Healthcare Providers & Services industry. The company's P/E ratio stands at -155.99, which is significantly below its recent high and slightly above its recent low. Other …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Trust Advisors LP Sells 23,908 Shares of Mettler-Toledo International, Inc. $MTD

First Trust Advisors LP significantly reduced its stake in Mettler-Toledo International, Inc. (MTD) by selling 23,908 shares, retaining 14,060 shares valued at approximately $17.7 million. Despite mixed analyst ratings and an average price target of $1,408.55, Mettler-Toledo exceeded quarterly earnings expectations with $8.91 EPS …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guardant Health Inc (GH) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Guardant Health Inc (GH), detailing its volatility, financial metrics, and investment risk. The company has a beta of 1.60, indicating higher volatility compared to the S&P 500, and is ranked 72nd out of 199 in the Healthcare …

GH main company
Sharemaestro market context Trend signal active 52 weeks +156.0% GH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Class Action Lawsuit Filed Against GeneDx Holdings Corp. (WGS) - Recover Losses - Contact Levi & Korsinsky Before August 3, 2026

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ:WGS) by Levi & Korsinsky, LLP, on behalf of investors who purchased securities between April 16, 2025, and May 4, 2026. The lawsuit alleges that GeneDx Holdings Corp. made false and misleading statements …

WGS main company
Sharemaestro market context Price above Trend Line 52 weeks -39.3% WGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ABCL|Abcellera Biologics Inc|Price:5.715|Chg%:+0.025

This article provides a comprehensive stock analysis of Abcellera Biologics Inc (ABCL) based on TradingKey's proprietary scoring system. ABCL's fundamentals are described as stable with high growth potential, and its valuation is considered fair within the Biotechnology & Medical Research industry. The report highlights …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adaptive Biotechnologies Q2 Net Loss Widens Despite Revenue Growth; Stock Down

(RTTNews) - Adaptive Biotechnologies Corp. (ADPT), a commercial-stage biotechnology company, reported financial results for the second quarter ended June 30, 2026, reflecting a wider net loss amid revenue growth. In addition, the company also provided an update on its full-year 2026 revenue outlook for …

ADPT main company
Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0% ADPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CareDx, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CDNA) 2026-07-30

CareDx, Inc. (CDNA) reported impressive Q2 2026 earnings, significantly beating EPS and revenue expectations. The company saw a 59.5% beat on EPS with $0.37 against an estimated $0.23, and revenue reached $132 million, surpassing the $114 million estimate by 15.7%. This strong performance was …

CDNA main company
Sharemaestro market context Trend signal active 52 weeks +249.4% CDNA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICON Public Limited Company 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ICLR) 2026-07-30

ICON reported strong Q1 2026 financial results, with gross bookings up 22% year-over-year and net business wins of $2.88 billion. The company reaffirmed its full-year 2026 guidance for revenue and adjusted diluted EPS, expecting modest sequential margin improvement. Strategic investments in central labs, oncology …

ICLR main company
Sharemaestro market context Trend signal active 52 weeks -7.2% ICLR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: ICON beats Q2 2026 estimates but shares slip premarket

ICON reported strong Q1 2026 financial results, with gross bookings up 22% year-over-year and net business wins of $2.88 billion. The company reaffirmed its full-year 2026 guidance for revenue and adjusted diluted EPS, expecting modest sequential margin improvement. Strategic investments in central labs, oncology …

ICLR main company
Sharemaestro market context Trend signal active 52 weeks -7.2% ICLR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context